Suppr超能文献

白内障超声乳化手术中前房内散瞳剂的再扩张

Redilatation with intracameral mydriatics in phacoemulsification surgery.

作者信息

Bäckström Gunnie, Behndig Anders

机构信息

Eye Clinic, Ornsköldsviks Hospital, Ornsköldsvik, Sweden.

出版信息

Acta Ophthalmol Scand. 2006 Feb;84(1):100-4. doi: 10.1111/j.1600-0420.2005.00546.x.

Abstract

PURPOSE

To determine whether intracameral mydriatics can redilate pupils that contract during phacoemulsification cataract surgery.

METHODS

A total of 80 patients were included in this prospective, randomized, double-blind study performed at Ornsköldsviks Hospital Eye Clinic. Of these, 60 patients had 0.6 microg/ml of epinephrine added to the balanced salt solution (BSS) used for irrigation and 20 patients did not. The patients in each group were randomized and given either an intracameral mydriatics (ICM) solution or placebo intracamerally after phacoemulsification and cortex cleaning. The pupil size was registered preoperatively, after cortex cleaning, 30 seconds after study injection, 2 mins after study injection and the day after surgery.

RESULTS

No clinically relevant differences were found preoperatively. In the epinephrine material a significantly longer operation time (p = 0.023) and more procedures requiring Vision Blue and Kelman-type tip in the placebo group might indicate diversity in the grade of cataract. There was a greater degree of contraction in the absence of epinephrine in the irrigation solution (2.3 +/- 1.0 mm in the ICM group and 3.2 +/- 0.7 mm in the placebo group) compared to in the presence of epinephrine. With no epinephrine ICM significantly redilated the pupils at 30 seconds (p < or = 0.001) as well as at 2 mins (p = 0.015).

CONCLUSION

We have shown that in cases with an intraoperative pupil contraction, ICM is effective in redilating the pupil. Insufficient adrenergic stimulation of the pupil dilator appears to be a major factor causing intraoperative pupil contraction during phacoemulsification cataract surgery.

摘要

目的

确定前房内散瞳剂能否使在白内障超声乳化手术过程中收缩的瞳孔重新散大。

方法

本前瞻性、随机、双盲研究在厄勒布鲁医院眼科诊所进行,共纳入80例患者。其中60例患者在用于冲洗的平衡盐溶液(BSS)中添加了0.6微克/毫升肾上腺素,20例患者未添加。每组患者在超声乳化和皮质清除术后随机接受前房内散瞳剂(ICM)溶液或前房内安慰剂。术前、皮质清除后、研究注射后30秒、研究注射后2分钟及术后第一天记录瞳孔大小。

结果

术前未发现临床相关差异。在肾上腺素组中,手术时间明显更长(p = 0.023),安慰剂组中更多手术需要使用视觉蓝和凯尔曼型探头,这可能表明白内障分级存在差异。与存在肾上腺素相比,冲洗液中不存在肾上腺素时瞳孔收缩程度更大(ICM组为2.3±1.0毫米,安慰剂组为3.2±0.7毫米)。在无肾上腺素的情况下,ICM在30秒时(p≤0.001)以及2分钟时(p = 0.015)能使瞳孔显著重新散大。

结论

我们已经表明,在术中瞳孔收缩的情况下,ICM能有效使瞳孔重新散大。瞳孔扩张肌的肾上腺素能刺激不足似乎是白内障超声乳化手术期间术中瞳孔收缩的主要因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验